239 related articles for article (PubMed ID: 34551289)
1. PBRM1 loss in kidney cancer unbalances the proximal tubule master transcription factor hub to repress proximal tubule differentiation.
Gu X; Enane F; Tohme R; Schuerger C; Radivoyevitch T; Parker Y; Zuberi E; Przychodzen B; Jha BK; Lindner D; Rini B; Saunthararajah Y
Cell Rep; 2021 Sep; 36(12):109747. PubMed ID: 34551289
[TBL] [Abstract][Full Text] [Related]
2. PBRM1 bromodomains variably influence nucleosome interactions and cellular function.
Slaughter MJ; Shanle EK; McFadden AW; Hollis ES; Suttle LE; Strahl BD; Davis IJ
J Biol Chem; 2018 Aug; 293(35):13592-13603. PubMed ID: 29986887
[TBL] [Abstract][Full Text] [Related]
3. Individual Bromodomains of Polybromo-1 Contribute to Chromatin Association and Tumor Suppression in Clear Cell Renal Carcinoma.
Porter EG; Dykhuizen EC
J Biol Chem; 2017 Feb; 292(7):2601-2610. PubMed ID: 28053089
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of the PBRM1 tumor suppressor gene amplifies the HIF-response in VHL-/- clear cell renal carcinoma.
Gao W; Li W; Xiao T; Liu XS; Kaelin WG
Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1027-1032. PubMed ID: 28082722
[TBL] [Abstract][Full Text] [Related]
5. PBRM1 Regulates the Expression of Genes Involved in Metabolism and Cell Adhesion in Renal Clear Cell Carcinoma.
Chowdhury B; Porter EG; Stewart JC; Ferreira CR; Schipma MJ; Dykhuizen EC
PLoS One; 2016; 11(4):e0153718. PubMed ID: 27100670
[TBL] [Abstract][Full Text] [Related]
6. PBRM1 (BAF180) protein is functionally regulated by p53-induced protein degradation in renal cell carcinomas.
Macher-Goeppinger S; Keith M; Tagscherer KE; Singer S; Winkler J; Hofmann TG; Pahernik S; Duensing S; Hohenfellner M; Kopitz J; Schirmacher P; Roth W
J Pathol; 2015 Dec; 237(4):460-71. PubMed ID: 26178300
[TBL] [Abstract][Full Text] [Related]
7. PBRM1-deficient PBAF complexes target aberrant genomic loci to activate the NF-κB pathway in clear cell renal cell carcinoma.
Yao X; Hong JH; Nargund AM; Ng MSW; Heng HL; Li Z; Guan P; Sugiura M; Chu PL; Wang LC; Ye X; Qu J; Kwek XY; Lim JCT; Ooi WF; Koh J; Wang Z; Pan YF; Ong YS; Tan KY; Goh JY; Ng SR; Pignata L; Huang D; Lezhava A; Tay ST; Lee M; Yeo XH; Tam WL; Rha SY; Li S; Guccione E; Futreal A; Tan J; Yeong JPS; Hong W; Yauch R; Chang KT; Sobota RM; Tan P; Teh BT
Nat Cell Biol; 2023 May; 25(5):765-777. PubMed ID: 37095322
[TBL] [Abstract][Full Text] [Related]
8. PAX8 activates metabolic genes via enhancer elements in Renal Cell Carcinoma.
Bleu M; Gaulis S; Lopes R; Sprouffske K; Apfel V; Holwerda S; Pregnolato M; Yildiz U; Cordoʹ V; Dost AFM; Knehr J; Carbone W; Lohmann F; Lin CY; Bradner JE; Kauffmann A; Tordella L; Roma G; Galli GG
Nat Commun; 2019 Aug; 10(1):3739. PubMed ID: 31431624
[TBL] [Abstract][Full Text] [Related]
9. Loss of PBRM1 Alters Promoter Histone Modifications and Activates ALDH1A1 to Drive Renal Cell Carcinoma.
Schoenfeld DA; Zhou R; Zairis S; Su W; Steinbach N; Mathur D; Bansal A; Zachem AL; Tavarez B; Hasson D; Bernstein E; Rabadan R; Parsons R
Mol Cancer Res; 2022 Aug; 20(8):1193-1207. PubMed ID: 35412614
[TBL] [Abstract][Full Text] [Related]
10. CCL5-dependent mast cell infiltration into the tumor microenvironment in clear cell renal cell carcinoma patients.
Liu T; Xia Q; Zhang H; Wang Z; Yang W; Gu X; Hou T; Chen Y; Pei X; Zhu G; He D; Li L; Xu S
Aging (Albany NY); 2020 Nov; 12(21):21809-21836. PubMed ID: 33177244
[TBL] [Abstract][Full Text] [Related]
11. The SWI/SNF Protein PBRM1 Restrains VHL-Loss-Driven Clear Cell Renal Cell Carcinoma.
Nargund AM; Pham CG; Dong Y; Wang PI; Osmangeyoglu HU; Xie Y; Aras O; Han S; Oyama T; Takeda S; Ray CE; Dong Z; Berge M; Hakimi AA; Monette S; Lekaye CL; Koutcher JA; Leslie CS; Creighton CJ; Weinhold N; Lee W; Tickoo SK; Wang Z; Cheng EH; Hsieh JJ
Cell Rep; 2017 Mar; 18(12):2893-2906. PubMed ID: 28329682
[TBL] [Abstract][Full Text] [Related]
12. Loss of PBRM1 expression is associated with renal cell carcinoma progression.
Pawłowski R; Mühl SM; Sulser T; Krek W; Moch H; Schraml P
Int J Cancer; 2013 Jan; 132(2):E11-7. PubMed ID: 22949125
[TBL] [Abstract][Full Text] [Related]
13. PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison.
Ozcan A; de la Roza G; Ro JY; Shen SS; Truong LD
Arch Pathol Lab Med; 2012 Dec; 136(12):1541-51. PubMed ID: 23194047
[TBL] [Abstract][Full Text] [Related]
14. Kid-1 expression is high in differentiated renal proximal tubule cells and suppressed in cyst epithelia.
Witzgall R; Obermüller N; Bölitz U; Calvet JP; Cowley BD; Walker C; Kriz W; Gretz N; Bonventre JV
Am J Physiol; 1998 Dec; 275(6):F928-37. PubMed ID: 9843910
[TBL] [Abstract][Full Text] [Related]
15. PBRM1 bromodomains associate with RNA to facilitate chromatin association.
De Silva SM; Dhiman A; Sood S; Mercedes KF; Simmons WJ; Henen MA; Vögeli B; Dykhuizen EC; Musselman CA
Nucleic Acids Res; 2023 May; 51(8):3631-3649. PubMed ID: 36808431
[TBL] [Abstract][Full Text] [Related]
16. Differentiation therapy and the mechanisms that terminate cancer cell proliferation without harming normal cells.
Enane FO; Saunthararajah Y; Korc M
Cell Death Dis; 2018 Sep; 9(9):912. PubMed ID: 30190481
[TBL] [Abstract][Full Text] [Related]
17. p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system.
Carvalho JC; Thomas DG; McHugh JB; Shah RB; Kunju LP
Histopathology; 2012 Mar; 60(4):597-608. PubMed ID: 22260386
[TBL] [Abstract][Full Text] [Related]
18. Genetic and epigenetic profiling indicates the proximal tubule origin of renal cancers in end-stage renal disease.
Ishihara H; Yamashita S; Liu YY; Hattori N; El-Omar O; Ikeda T; Fukuda H; Yoshida K; Takagi T; Taneda S; Kondo T; Nagashima Y; Tanabe K; Ushijima T
Cancer Sci; 2020 Nov; 111(11):4276-4287. PubMed ID: 32860304
[TBL] [Abstract][Full Text] [Related]
19. PBRM1 regulates proliferation and the cell cycle in renal cell carcinoma through a chemokine/chemokine receptor interaction pathway.
Wang H; Qu Y; Dai B; Zhu Y; Shi G; Zhu Y; Shen Y; Zhang H; Ye D
PLoS One; 2017; 12(8):e0180862. PubMed ID: 28846693
[TBL] [Abstract][Full Text] [Related]
20. Elevated histone H3 acetylation and loss of the Sp1-HDAC1 complex de-repress the GM2-synthase gene in renal cell carcinoma.
Banerjee A; Mahata B; Dhir A; Mandal TK; Biswas K
J Biol Chem; 2019 Jan; 294(3):1005-1018. PubMed ID: 30463940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]